Alkaloid-rich fraction of Himatanthus lancifolius contains anti-tumor agents against leukemic cells

5Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

Abstract

The effects of the alkaloid-rich fraction of Himatanthus lancifolius (Müll. Arg) Woodson on normal marrow cells and leukemic cell lines were investigated. After 48 h exposure, the proliferation assay showed significant cell growth inhibition for Daudi (0.1-10 μg/mL), K-562 (1-10 μg/mL), and REH cells (10-100 μg/mL), yet was inert for normal marrow cells. A similar inhibition profile was observed in clonogenic assays. This alkaloid-rich fraction, in which uleine is the main compound, showed no signs of toxicity to any cells up to 10 μg/mL. Cell feature analyses after induction of differentiation showed maintenance of the initial phenotype. Flow cytometric expression of Annexin-V and 7-AAD in K-562 and Daudi cells has indicated that the cells were not undergoing apoptosis or necrosis, suggesting cytostatic activity for tumor cells.

Cite

CITATION STYLE

APA

De Lima, M. P., Hilst, L. F., Mattana, F. V. R., Santos, C. A. D. M., & Weffort-Santos, A. M. (2010). Alkaloid-rich fraction of Himatanthus lancifolius contains anti-tumor agents against leukemic cells. Brazilian Journal of Pharmaceutical Sciences, 46(2), 273–280. https://doi.org/10.1590/S1984-82502010000200014

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free